Results 91 to 100 of about 12,004 (149)

Programmed cell death in cancer: targeting necroptosis to kill tumor cell. [PDF]

Cell Death Discov
Liang J, Tan C, Li X, Fan J, Liu B.
europepmc   +1 more source

Toll-like Receptor 3 as a Context-Dependent Molecular Switch in Epithelial Cancers: Balancing Cell Death and Tumor-Supportive Programs. [PDF]

Int J Mol Sci
Pérez-Baños A, Tittarelli A.
europepmc   +1 more source

Focus on necroptosis: its role in the pathogenesis and therapeutic potential of osteoarthritis. [PDF]

Front Immunol
Ouyang Y, Liao H, Kang W, Li F, Shen H.
europepmc   +1 more source

[Fecal microbiota transplantation attenuates gastrointestinal inflammation in murine acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation by inhibiting RIPK1/RIPK3-mediated necroptosis]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Li Y, Niu HS, Lu XL, Li XC, Xiao M, Wang Y, Yang SJ, Guo YY, Sun Y.   +8 more
europepmc   +1 more source

miR-3921 functions as a tumor suppressor and negatively regulates RIPK1 in gastric cancer. [PDF]

PeerJ
Xu C, Long Z, Li X, Liu P.
europepmc   +1 more source

Emerging Roles of Regulated Cell Death-mediated Inflammation in Pathophysiology of Ocular Diseases. [PDF]

J Ophthalmic Vis Res
Sheibani N.
europepmc   +1 more source

USP25 in atherosclerosis: a new kid on the block. [PDF]

EBioMedicine
Ilyas I, Xu S.
europepmc   +1 more source

Multimodal analysis of cell-free DNA identifies epigenetic biomarkers for amyotrophic lateral sclerosis diagnosis and progression. [PDF]

J Clin Invest
Michels S, Chen C, Ruf WP, Garcia Garcia MM, Arnold FJ, Wu Z, Bennett CL, Shams D, Thompson LM, Walker AC, Dickson DW, Petrucelli L, Dorst J, Prudencio M, Li W, La Spada AR.   +15 more
europepmc   +1 more source

Aspartate deficiency amplifies cGAS-STING signaling in antitumor immunity. [PDF]

J Clin Invest
Liao Y, Wang H, Liu H, Chen X, Sun R, Li X, Yang Z, Liu C, Wu W, He Z, Zhao Y, Mao Y, Ye D, Yang H.   +13 more
europepmc   +1 more source

RIPK1 as a potential target to augment DC efficacy in tumor immunotherapy. [PDF]

Cancer Immunol Immunother
Mao L, Ou Y, Zhang Y, Wang M, Dong G, Khanniche A, Wang H, Wu Z, Zhang H, Hu L, Kong X.   +10 more
europepmc   +1 more source